定义:心力衰竭(Heart Failure, HF):是各种原因引起心脏结构或功能改变,导致心室充盈和(或)射血功能受损,心排血量不能满足机体组织代谢需要,以肺循环和(或)体循环淤血,器官、组织血液灌注不足为临床表现的一组综合征,主要表现为呼吸困难、体力活动受限和体液储留。 分类 按部位 左心衰:肺循环淤血 左心泵血减少→...
Heart failure biomarkers BNP and NT-proBNP detection using optical labelsOlga A. Goryacheva aTatiana D. Ponomaryova aDaniil D. Drozd aAlina A. Kokorina aTatiana Yu. Rusanova aPradyumna K. Mishra bIrina Yu. Goryacheva a
BNP /N-terminal pro-BNP (NT-proBNP) levels: High sensitivity and predictive value for HF Recommended for those presenting with: Dyspnea (for suspected HF) Acute decompensation Chronic HF (to help determine prognosis and disease severity) Elevated levels associated with ↑ short- and long-term...
BIOSTAT-CHF是一项多中心临床研究,包括建模队列中的2516名患者。纳入新发或心衰恶化的患者,心衰定义为左心室射血分数(LVEF)≤40%或B型利钠肽(BNP)>400 pg/mL或N端B型利钠肽原(NT-proBNP)>2000 pg/mL。数据在独立的BIOSTAT-CHF...
利钠肽[NP,包括B型利钠肽(BNP)和BNP的氨基末端激素(NT-proBNP)]是心力衰竭(HF)管理的金标准生物标志物,1常规呈报/入院时NP水平用于诊断和预后目的。2出院/随访时的NP水平也显示出与预后的关联,3和HF治疗后的NP水平为调整风险增加了更多价值。4然而,在临床实践中,
Objective To compare the capabilities of NT-proBNP and BNP in diagnosis of heart failure complicated with acute cerebral infarction. Methods EP15-A2 document was employed to verify the precision and accuracy of NT-proBNP and BNP assays on chemiluminescence analyzer Cobas E601 and ADVIA Centaur ...
The American College of Cardiology, American Heart Association, and Heart Failure Society of America (ACC/AHA/HFSA) guidelines recommend the following for the diagnosis of HF [4] : Levels of: B-type natriuretic peptide/N-terminal BNP (BNP/NT-proBNP), urea and electrolytes, fasting glucose and...
in research,BNP and NT-proBNP may become one of the reliable biochemical indexes respectively in the early diagnosis of diastolic heart failure.Moreover,they may have clear boundary values in the field in future,and possibly making the diagnosis of diastolic heart failure simple,accurate and ...
通过分析自主神经张力(HRV)和反射(HR湍流)的标志物和心脏电稳定性(T波交替、R波和T波异质性)以及评估非持续性室性心动过速发作的负荷,证实了CVN的长期保护作用。38有趣的是,发现CVN对ANTHEM-HF的有益作用独立于基线N-末端前BNP(NT-proBNP)水平...
Variability of NT-proBNP levels in heart failure: implications for clinical applicationBNP, B-type natriuretic peptideCV, coefficient of variationNT-proBNP, N-terminal pro-brain natriuretic peptideSCV, serial change valuenatriuretic peptidesurine